9/28/2015. Approaches to the Treatment of Pain in an Environment of Diversion Friday October 3, 2015. Outline. Accuracy of Diagnoses



Similar documents
Treatment of Anxiety in the Methadone Maintained Patient

After seeing a patient on a Diversion Alert installment..

Information for Pharmacists

Care Management Council submission date: August Contact Information

5317 Cherry Lawn Rd, Huntington, WV Phone: (304) Fax: (304) Welcome

MAT Disclosures & Consents 1 of 6. Authorization & Disclosure

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Financial Disclosures

Psychopharmacotherapy for Children and Adolescents

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Sample Patient Agreement Forms

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

TREATMENT-RESISTANT DEPRESSION AND ANXIETY

PATIENT TREATMENT AGREEMENT

American Dental Association Providers Clinical Support System on Opioid Therapies Webinar

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

Opioid overdose can occur when a patient misunderstands the directions

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

San Mateo County Alcohol and Other Drug Services New Medication Policy

Southlake Psychiatry. Suboxone Contract

Prescription Medication Abuse: Skills for Prevention and Intervention

Managing Chronic Pain in Adults with Substance Use Disorders

What you need for Your to know Safety about longterm. opioid pain care. What you need to know about long-term opioid

Community Center Readiness Guide Additional Resource #17 Protocol for Physician Assistants and Advanced Practice Nurses

Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium

MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER

Falling Between Two Stools. Dual Diagnosis: The need for multidisciplinary awareness and cooperation. Eoin Stephens

How To Treat A Drug Addiction

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Depression Assessment & Treatment

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Benzodiazepine Detoxification and Reduction of Long term Use

Management of benzodiazepine misuse

Care Manager Resources: Common Questions & Answers about Treatments for Depression

Identifying and Treating Dual-Diagnosed Substance Use and Mental Health Disorders. Presented by: Carrie Terrill, LCDC

VAADA Conference 2015 Benzodiazepines: Are they making your client s life hell?

Question one. 1. You increase her to 90mg 2. You increase her to 95mg 3. You hold her dose where it is (80mg)

MEDICAL ASSISTANCE BULLETIN

COUNTY OF LOS ANGELES - DEPARTMENT OF MENTAL HEALTH OFFICE OF THE MEDICAL DIRECTOR. 3.4 PARAMETERS FOR THE USE OF ANXIOLYTIC MEDICATIONS October 2014

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

OVERVIEW OF MEDICATION ASSISTED TREATMENT

Dual Diagnosis in Treatment

Opioid Treatment Services, Office-Based Opioid Treatment

Guidelines for the Prescribing, Supply and Administration of Methadone and Buprenorphine on Transfer of Care

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center

MEDICAL ASSISTANCE BULLETIN

Opioid Agreement for Center for Pain Management S.C.

BENZODIAZEPINE CONSIDERATIONS IN WORKERS COMPENSATION: IMPLICATIONS FOR WORK DISABILITY AND CLAIM COSTS By: Michael Erdil MD, FACOEM

Uncertainty: Was difficulty falling asleep and hypervigilance related to fear of ventricular tachycardia returning, or fear of being shocked again?

January, Developed by

Addiction Psychiatry Fellowship Rotation Goals & Objectives

How To Treat Anorexic Addiction With Medication Assisted Treatment

Treatment of opioid use disorders

Fraud, Waste and Abuse

1. According to recent US national estimates, which of the following substances is associated

Opioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015

2012 Carilion Prescription Drug Abuse Educational Forum 10/6/2014. Disclosure Statement

Abstral Prescriber and Pharmacist Guide

Support to Primary Care from Derbyshire Substance Misuse Service for prescribed / OTC drug dependence

Appendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages

Michael Brennan, MA, LMHC Providence St. Peter Hospital Crisis Services

Non medical use of prescription medicines existing WHO advice

Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement

Questions to Ask About Medications and Herbal Supplements

Governor s Task Force on Mental Health and Substance Use.

SECTION VII: Behavioral Health Services

PRESCRIPTION PAINKILLER OVERDOSES

REFERRAL FORM FOR ADMISSION TO HOMEWOOD HEALTH CENTRE

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Traumatic Stress. and Substance Use Problems

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II

Pain, Addiction & Methadone

DSM 5 Opioid Related Disorders. Dr. Phil O Dwyer Oakland University Brookfield Clinics

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain

CO-OCCURRING DISORDERS. Michaelene Spence MA LADC 8/8/12

North Bay Regional Health Centre

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

Amphetamines Addiction

Opioid Treatment Agreement

Benzodiazepine & Z drugs withdrawal protocol

DEPARTMENT OF PSYCHIATRY Centre Street Boston, MA 02130

Prescription Drug Addiction

Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

August A. Introduction

Background & Significance

Alcohol Overuse and Abuse

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health

Updated on Substance Abuse Treatment Centers in New Mexico

MEDICAL POLICY Treatment of Opioid Dependence

Patient Information and Consent to Treatment with Buprenorphine

Buprenorphine-containing Transmucosal products for Opioid Dependence (BTOD) Risk Evaluation and Mitigation Strategy (REMS)

Approaches to Treatment of Youth with Opioid Addiction. Marc Fishman MD Mountain Manor Treatment Center Johns Hopkins University

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Transcription:

Approaches to the Treatment of Pain in an Environment of Diversion Friday October 3, 2015 Michigan Pharmacists Association Michael P Notorangelo DO ABAM CMRO Outline 1. Accuracy of Diagnoses 2. Choice of Medications 3. Dispensing of Medications 4. Maximizing Delivery of Medication, Optimus Technique for Buprenorphine 5. Supervision of Medication 6. Nonpharmacologic Treatment 7. Behaviors to be aware of Accuracy of Diagnoses Opiate Use and Dependence are Complicated: (+) Are critically important for severe pain (+) Opiates are amazing antidepressants, anxiolytics, memory blockers (+) Often treat co occurring/underlying conditions, including; Depression, PTSD,( hugely underreported in the UP) GAD, OCD, ADHD 1

Accuracy of Diagnoses ( ) Opiates are the most addictive of substances ( ) By treating /obscuring Depression, PTSD, Anxiety, ADHD, complicates the diagnoses and patients willingness to D/C use of opiates ( )Opiate W/D mimics Depression, Anxiety, ADHD further complicating accurate diagnosis Prescribers historically are not taught addiction and most are not trained in Psychiatry Confounded further by the push to use Opiates CASE STUDY 30 yo wf, c/o diffuse pain, anxious all the time Norco D/C d, SSRI s don t work, bad side effects Only relief Xanax, she increased up to 1mg tid PMH past bullemia, PSH neg, All NKDA FH F alcoholic Soc Hx social drinker ROS acute Op/W/D, otherwise noncontributory Differential Dx:??? CASE STUDY Differential Dx: Opiate Dependence Acute Opiate W/D, + UDS(admits to buying opiates off the street ) Anxiety Opiate withdrawal anxiety? Anxiety Disorders? Alcohol Withdrawal? Stimulant Abuse/Dependence? ADHD? 2

Accuracy of Diagnoses Misdiagnoses are more common than we think!! EX: Hyperactive subcomponents of ADHD often misdiagnosed as Anxiety I m Anxious! will not respond to and poorly tolerate SSRI s (Noradrenergic based) often prescribed Benzo s, often become Dependent (predisposed to Addiction) Bottom Line: Doc s need to be MORE PRECISE with diagnosing!!! Choice of Medications Nonaddictive Medications work well for ADHD (Off Label = OL) Guanfacine (OL,A), Atomoxetine, Clonidine(OL,A), also possibly are Venlafaxine (OL), Buproprion (OL) Nonaddictive medication works well in PTSD for flashbacks Prazosin (OL) orthostasis limits use, Doxazosin (OL) Nonaddictive Medications work well for true Anxiety Disorders, the higher potentcy SSRI S, that necessitate longer periods of time to see the full response, 6 to 8 months, versus 1 2 for depression, As well as necessitating the higher range of dosing Dosing of Medication Lowest Effective Dose of Addictive Meds?? Very difficult if used to self medicate Must Identify and aggressively treat underlying Depression, Anxiety, ADHD, PTSD, to get there!! Buprenorphine provides some clarity in those Opiate dependent to diagnose underlying conditions, then treatment facilitates possible taper and D/C of Buprenorphine Aggressive SSRI s minimizes need for Benzo s 3

Dispensing of Medication I prescribe the exact # of CS to get to the next appointment at the lowest established effective dose. * No replacements under any circumstances. *Optimus Technique: Establishing lowest Effective dose of Suboxone, initiated during active opiate withdrawal. 1. No Nicotine or caffeine for 1 hour PTD 2. Rinse mouth with warmest tap water tolerable 3. put ¼ of 8mg strip under tongue and tilt head forward down, reading something/ tech neck for 15 minutes. 4. Wait at least 2 hours between doses, minimizing how much used, limited to 8mg strip over 12 24 hours. Supervision of Medication Pill Counts, Pill Counts, Pill Counts!!! Pill Count form I devised in cooperation with Todd of Peoples Pharmacy in Escanaba. 1. Call patient at random to come in, in 24 hrs, with their Medication to the pharmacy # they provide 2. We call the Pharmacy, tell them we are doing a count, get their fax and contact person then fax our form. Pharmacy faxes back completed form 4

Use of Nonpharmacologic Treatment Accupunture / Accudetox Manipulation / Massage Meditation Biofeedback Exercise /Physical Therapy Psychotherapy Diet / Suppliments Behaviors to be aware of Obvious ones: Prescription doesn t look right MAP lights up More difficult: Girlfriend comes in and picks up his script, only they are no longer together Patient doesn t look right, sunken eyes, steely stare, scabs on face, twitchy, thin build = the look of Crystal Meth = could be psychotic enough to be dangerous Epidemiology Of 14,175 college students, from 26 campuses, 14.7% are diverting, including; stimulants(52.6%), anxiolytics (38.4%), antidepressants(17.4%) < 20% using Psychotropics with alcohol or other illicits told their HCP. Risk factors for misuse of stimulants included; heavy alcohol use, white race, fraternity sorority membership, low GPA, competitive University. 5

Conclusion Pain treatment is complicated by the complex Opiate/Pain /Psychiatry interface Accurate diagnosis and treatment of underlying psychiatric conditions is critical to minimize the carnage associated with addictive medications Nonaddictive alternatives offer effective relief Careful dosing, monitoring and supervision of controlled substances is critical for safety 6